SPY
752.88
+0.10%
QQQ
682.55
+0.21%
BTC/USD
76,691.96
+0.02%
DIA
519.00
−0.07%
GLD
362.74
+0.30%
TLT
81.61
−0.15%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Myomo Inc
MYO
AMEX
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.20
-0.04
-3.23%
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings in 6 days from now on Mon Nov 9th, after the market close
Myomo Financials
Myomo (MYO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Myomo Sees Q3 Sales $11.500M-$12.000M vs $11.168M Est
Myomo (AMEX:MYO) sees Q3 sales of $11.500 million-$12.000 million vs $11.168 million analyst estimate.
Benzinga Newsdesk
PRO
Myomo Raises FY2026 Sales Guidance from $43.000M-$46.000M to $45.000M-$47.000M vs $44.434M Est
Myomo (AMEX:MYO) raises FY2026 sales outlook from $43.000 million-$46.000 million to $45.000 million-$47.000 million vs $44.434 million estimate.
Benzinga Newsdesk
PRO
Myomo Q2 EPS $(0.09) Beats $(0.10) Estimate, Sales $11.704M Beat $10.352M Estimate
Benzinga Newsdesk
PRO
Myomo Sees Q2 Sales $10.300M-$10.800M vs $10.457M Est
Myomo (AMEX:MYO) sees Q2 sales of $10.300 million-$10.800 million vs $10.457 million analyst estimate.
Benzinga Newsdesk
PRO
Myomo Affirms FY2026 Sales Guidance of $43.000M-$46.000M vs $48.591M Est
Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 million-$46.000 million vs $48.591 million estimate.
Benzinga Newsdesk
PRO
Myomo Q1 EPS $(0.07) Beats $(0.08) Estimate, Sales $10.113M Miss $10.486M Estimate
Myomo (AMEX:MYO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same period
Benzinga Newsdesk
